BostInno – How this Harvard-MGH startup plans to transform brain health management – Boston Business Journal

Related Articles:

• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease May 5, 2020 “Both caffeine and urate possess neuroprotective properties via adenosine receptor antagonist and antioxidant actions, respectively,” explained lead investigator Rachit Bakshi, PhD, Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA. “They both have protective properties in animal models of PD, raising the possibility of their disease-slowing potential.” Researchers therefore investigated whether these reduced risk factors are…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Medicare Coverage and Parkinson’s February 7, 2019 Written by Danielle Kunkle Roberts, Forbes Finance Council member and co-owner of Boomer Benefits No one plans to spend their retirement battling a chronic illness, yet people on Medicare are diagnosed with such illnesses all the time. Dealing with a progressive chronic condition like Parkinson’s can be particularly devastating and also expensive. Parkinson’s affects more than one million people in…
• New Therapy Using Patients’ Own Cells May Halt Parkinson’s Progression, Case Study Suggests May 21, 2020 A new therapeutic approach in which patient-derived dopamine-producing neurons are transplanted into the brain may halt Parkinson’s disease progression, a case report suggests. The approach uses patient-derived induced pluripotent stem cells (iPSCs),  which are cells collected from the skin or blood that researchers can reprogram in a lab dish to revert them back to a stem cell-like state that has…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• How Does Medicare Cover Parkinson's Disease? February 20, 2019 Guest post by Danielle K. Roberts of Boomer BenefitsAs far as chronic illnesses go, Parkinson’s Disease can be an expensive health condition to manage.  Parkinson’s News Today reported that yearly drug expenses for a person with PD can exceed $2,500 and costs of surgery may exceed $100K. The combined direct and indirect costs in the U.S. is estimated to be…
• Meet the Newest Davis Phinney Foundation Leaders in Parkinson’s December 8, 2020 We are delighted to announce the creation of The Davis Phinney Foundation Inclusion, Diversity, Equity, and Access (IDEA) Advisory Board. This team of renowned healthcare providers and leaders in the fields of equity and inclusion will play an integral role in our work to better understand and change deeply rooted inequities in healthcare that black, brown, and indigenous communities; LGBTQ+;…
• FDA OKs Boston Scientific’s Brain Stimulation System for Parkinson’s Patients December 14, 2017 The U.S. Food and Drug Administration has approved Boston Scientific’s Vercise Deep Brain Stimulation system to help Parkinson’s patients control their movement. Europe and Australia have already approved the system — the first to target specific nerve cells in the brain. It does this by stimulating electrodes that surgeons implant there. “This [U.S.] approval marks an important step for patients who will…